Introduction
============

*Blastocystis* is a common anaerobic unicellular eukaryotic parasite of humans with a large variety of non-human hosts with a more or less global distribution. The genus comprises at least 17 ribosomal lineages, the so-called "subtypes", which are arguably separate species ([@B1]). Nine of these subtypes, ST1-ST9, have been detected in humans, with ST1-ST4 being the most common ([@B2]). Molecular epidemiological surveys have been carried out in several countries to elucidate the genetic diversity of *Blastocystis* in different hosts, primarily to identify the level of host specificity, the possibility of zoonotic transmission, and whether certain subtypes could be linked to diseases in humans ([@B1]). However, only few countries outside Europe have published data on the genetic diversity of *Blastocystis* in different hosts ([@B3], [@B4]); Iran is among these countries.

To our knowledge, few Iranian studies have been published to date aiming to elucidate the distribution of *Blastocystis* subtypes in humans ([@B5]-[@B14]). These studies used different methodologies for identifying and differentiating *Blastocystis* subtypes. State-of-the-art subtyping of *Blastocystis* involves barcoding its original methods to detect *Blastocystis* subtypes ([@B15]). We aimed to expand the knowledge on *Blastocystis* subtypes existing in humans in southwest of Iran using state-of-the-art subtyping.

Methods
=======

**Subjects**

Prior to the sample collection, all participants were informed about the procedures. After taking a written consent, a personal information questionnaire was administered to each participant to inquire about age, sex, signs and symptoms, such as abdominal pain, diarrhea, dysentery, vomiting, nausea and constipation. The names of the admitted individuals in the medical laboratories and the results of used methods (Direct slide smear, culture and PCR) were written daily in check-list.

A total of 618 stool samples were collected from individuals referred to 16 medical laboratories of Ahvaz over a period of one year from September 2014 to September 2015.

**Parasitological and Statistical Analysis**

All 618 fecal samples were examined by direct smear (wet mount with Lugol's staining), formalin ether concentration technique, Ziehl-Neelsen and trichrome staining in order to enable detection of Cryptosporidium spp. and *Entamoeba*. sp, respectively, and were also processed by xenic in vitro culture in HSr +S medium \[Horse serum, ringer & starch rice (Razi Serum Institute, Iran)\] ([@B16]). After 5-7 days, sediments of cultures were studied by microscopic examination. Data were analyzed using SPSS software, version 16 (SPSS, Chicago, IL, USA), with Chi-square and Fisher's exact test.

**DNA extraction and PCR amplification**

After 5-7 days of cultivation, DNA of positive cultures were extracted from 200 µLit of the HSr + S culture medium using a commercial DNA extraction kit (Yekta-Tajhiz Azma stool mini kit, Iran) according to the manufacturer's instructions. DNA was also extracted from stool deemed positive for Blastocystis by microscopy. A 620 bp fragment from 18S rRNA gene was amplified using the DNA barcoding method using RD5 and BhRDr primers as previously described ([@B15]). PCR was performed using the Taq DNA Polymerase Master Mix Red (Amplicon, Denmark). The reaction mixture contained 5 µL of distilled water, 7.5 µL master mix, 20 pmoL forward and reverse primers and about 100-500 ng/µL of extracted DNA in a final volume of 15 µL. DNA from a known Blastocystis and a blank containing all PCR reagents but no DNA were included in each set of PCR as positive and negative controls, respectively. PCR products were electrophoresed and visualized with 1.5% agarose gels stained with ethidium bromide.

**Sequence analysis and accessions**

Ab1 files available from sequencing were manually edited and sequences were queried using the standard nucleotide BLAST algorithm provided by NCBI (http://www.ncbi.nlm.nih.gov/), the Blastocystis subtype \[18S rRNA\] and Sequence Typing (MLST) database (http://pubmlst.org/blastocystis/), to obtain information on subtype and subtype alleles, whenever applicable ([@B17]). The nucleotide sequence of 24 reported data in the present study were submitted to the GenBank/EMBL/DDBJ database under accession number KY312690 to KY312705 and MF072942 to MF072949.

**Ethical clearance**

All procedures of this study were approved by the Ethics Committee of the Shahid Beheshti University of Medical Science (SBMU), Iran, before the beginning of the study. All participants were informed about the study procedures and written informed consents were obtained from all of them prior to sample collection.

###### 

Frequency of *Blastocystis*in 16 medical laboratories in Ahvaz, southwest Iran

  -----------------------------------------------------------------
  Medical laboratory   No. of Samples   Positive\     Negative\
                                        N (Percent)   N (Percent)
  -------------------- ---------------- ------------- -------------
  Baghaii hospital     25               13 (52.0)     12 (48.0)

  Abozar               43               9 (21.0)      34 (79.0)

  Pastour              38               6 (15.7)      32 (84.3)

  Golestan             42               8 (19.0)      34 (81.0)

  Razi                 44               9 (20.4)      35 (79.6)

  Imam Khomeini        24               5 (21.0)      19 (79.0)

  Amir al moemenin     31               11 (35.4)     20 (64.6)

  Naft                 54               16 (29.6)     38 (70.4)

  Shahid Rajaii.       100              22 (22.0)     78 (78.0)

  Jihad daneshgahi     57               7 (12.2)      50 (87.8)

  DR Jalali            46               11 (24.0)     35 (76.0)

  Amir Kabir           25               4 (16.0)      21 (84.0)

  Mehr.                16               5 (31.2)      11 (68.8)

  DR Naghash           45               7 (15.5)      38 (84.5)

  Shahid Karami        23               12 (52.2)     11 (47.8)

  Shafa                5                1 (20.0)      4 (80.0)

  Total                618              146 (23.62)   472 (76.38)
  -----------------------------------------------------------------

###### 

Frequency of *Blastocystis* sp. isolated from humans based on demographic variables of age, sex and season in subjects referred to the medical laboratories of Ahvaz, southwest Iran

  ---------------------------------------------------------------------------------------
  Variables    Examined individuals (N)   Infected with *Blastocystis*N (%)   *P* value
  ------------ -------------------------- ----------------------------------- -----------
  Sex\         325\                       85 (26.15%)\                        0.141
  Male\        293                        61 (20.81%)                         
  Female                                                                      

  Age group\   131\                       23 (17.55)\                         0.023
  10≥\         78\                        12 (15.4)\                          
  11-25\       39\                        16 (41)\                            
  26-40\       87\                        22 (25.3)\                          
  41-55\       145\                       38 (26.2)\                          
  56-70\       138                        35 (25.3)                           
  ≤71                                                                         

  Season\      152\                       47 (30.92%)\                        0.001
  Spring\      150\                       44 (29.33%)\                        
  Summer\      164\                       37 (22.56%)\                        
  Autumn\      152                        18 (11.84%)                         
  Winter                                                                      
  ---------------------------------------------------------------------------------------

Results
=======

Out of 618 collected stool samples, 325 (52.6%) were from men and 293 (47.4%) were from women. Samples were randomly collected from individuals referred to the 16 laboratories of Medical centers in 8 regions of Ahvaz and Blastocystis sp was seen in 146 (23.62%) samples ([Table 1](#T1){ref-type="table"}). [Table 2](#T2){ref-type="table"} shows the frequency of positive Blastocystis isolates based on demographic variable of sex, age, and different seasons. In this study, 40.29% of the participants (249/618) were infected by one or more pathogenic or non-pathogenic intestinal parasites. Single parasites were seen in 198 (32.03%) of the specimens, while only 3 (0.48%) of the patients were infected with helminthes. [Table 3](#T3){ref-type="table"} shows the prevalence of different intestinal parasites in the collected samples. Co-infections with two or three parasites were found in 32 (5.17%) of positive samples. Frequency of infection was higher in spring and summer and the correlation between season and presence of Blastocystis was significant (P≤0.001). However, no significant correlation was found between sex and infection ([Table 2](#T2){ref-type="table"}).

In microscopic study, *Blastosistis* sp. was seen in 116 (18.77%) samples, while 146 (23.6%) samples grew in culture media ([Figure1](#F1){ref-type="fig"}).

Among the participants, 256 (41.42%) who were referred to the medical laboratories for checkup had no symptoms and 362 (58.58%) individuals suffered from at least one gastrointestinal symptom. In the symptomatic patients, totally 96 (26.51%) Blastocystis sp were isolated ([Table 4](#T4){ref-type="table"}). A significant correlation was found between stomach pain, diarrhea and Blastocystis infection (P≤0.01).

In molecular study, all 146 (23.62%) positive culture isolates were given expected amplicon. From those positive isolates, 24 positive PCR samples were randomly sequenced. Three subtypes, including ST1 (5/20.83%), ST2 (5/20.83%), and ST3 (14/58.34%), were identified. While most patients suffered from abdominal pain and diarrhea, no significant correlation was found between symptoms and subtypes ([Table 5](#T5){ref-type="table"}).

###### 

Frequency of intestinal parasites from individuals referred to the medicallaboratories, in Ahvaz, Khuzestan province, Southwest Iran (2014-2015)

  -------------------------- ------------------------------------- ---------------------------------------
  Parasite                   NO.                                   \%
  *Blastocystis*sp.          146                                   23.78
  *Endolimax nana*           34                                    5.5
  *Entamoeba coli*           32                                    5.17
  *Giardia lambelia*         26                                    4.2
  *Chilomastix mesnelii*     3                                     0.48
  *Cryptosporidium.spp.*     2                                     0.32
  *E.histolytica/E.dispar*   2                                     0.32
  *Dientamoeba fragilis*     1                                     0.16
  *Total protozoa*           246                                   39.80
  *Hymenolepis nana*         2                                     0.32
  *Oxyur*                    1                                     0.16
  Total parasites            249[\*](#TFN1){ref-type="table-fn"}   40.29[\*](#TFN1){ref-type="table-fn"}
  -------------------------- ------------------------------------- ---------------------------------------

Co-infections with two or three parasites were found in 32 (5.17%) of the positive samples

![Frequency of *Blastocystis*sp. identified by microscopy and culture media from individuals who referred to the medical laboratories in Ahvaz (2014-2015](GHFBB-10-235-g001){#F1}

###### 

Frequency of *Blastocystis* sp. according to clinical manifestation among individuals who referred to the medical laboratories in Ahvaz (N=618

  -----------------------------------------------------------------------------------------------------------
  Clinical features           Examined individuals (N)   Infected with *Blastocystis* sp N (%)   *P.* value
  --------------------------- -------------------------- --------------------------------------- ------------
  Stomach pain                                                                                   

  Yes\                        181\                       51 (28.2%)\                             0.094
  No                          437                        94 (21.5%)                              

  Diarrhea                                                                                       

  Yes\                        61\                        22 (36.1%)\                             0.014
  No                          557                        123 (22.1%)                             

  Dysentery                                                                                      

  Yes\                        6\                         3 (50%)\                                0.145
  No                          612                        142 (23.2%)                             

  Vomiting                                                                                       

  Yes\                        31\                        6 (19.4%)\                              0.749
  No                          586                        138 (23.5%)                             

  Nausea                                                                                         

  Yes\                        90\                        28 (31.1%)\                             0.086
  No                          528                        117 (22.2%)                             

  Constipation                                                                                   

  Yes\                        18\                        5 (27.8%)\                              0.876
  No                          600                        140 (23.3%)                             

  In appetence                                                                                   

  Yes\                        209\                       61 (29.2%)\                             0.21
  No                          409                        84 (20.5%)                              

  Group study                                                                                    

  Patients\                   362\                       96 (26.51%)\                            0.017
  Asymptomatic individuals\   256\                       50 (19.53%)\                            
  Total                       618                        146 (23.6%)                             
  -----------------------------------------------------------------------------------------------------------

###### 

Frequency of *Blastocystis* sp. according to gastrointestinal disorders and subtypes among individuals who referred to the medical laboratories in Ahvaz

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  P-Value   Subtypes\                                                                      Symptom[\*](#TFN2){ref-type="table-fn"}       
            ST1 ST2 [\*](#TFN2){ref-type="table-fn"} ST3[\*](#TFN2){ref-type="table-fn"}                                                 
  --------- ------------------------------------------------------------------------------ ----------------------------------------- --- ----------------------------
  0.486     4                                                                              3                                         3   Stomach pain, Inappetence

  0.967     1                                                                              4                                         0   Stomach pain, Nausea

  0.87      2                                                                              1                                         0   Stomach pain, Constipation

  0.758     4                                                                              1                                         1   Stomach pain, Diarrhea

  0.967     1                                                                              0                                         0   Stomach pain, Vomiting

  0.967     0                                                                              0                                         0   Diarrhea, Vomiting

  0.967     0                                                                              0                                         1   Nausea, Vomiting

  0.967     3                                                                              0                                         0   Inappetence, Constipation

  1.0       0                                                                              0                                         0   Dysentery

            14                                                                             5                                         5   Total subtypes
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

Subtypes were seen sometimes in two or more symptoms

Discussion
==========

*Blastocystis* is the most common parasite that infects the gastrointestinal tract of humans and a wide range of animals, including mammals, birds, reptiles, and arthropods, with a worldwide distribution. The purpose of this study was to improve our understanding of the molecular epidemiology of human Blastocystis, focusing on 618 randomly stool collected from 16 medical laboratory of Ahvaz in one year.

In the present study, the prevalence rate of *Blastocystis* was 23.62%. In developing countries, *Blastocystis* has a higher prevalence (30-50%) compared to developed countries (1.5-10%) ([@B17]). A noticeable result was obtained (30/20.54% out of 146 positive) in comparison to positive microscopy results when all studied isolates were cultivated in HSr + S medium ([@B16]). Therefore, cultivation not only increases positive samples, but the positive culture media is very useful for DNA extraction. Our findings corroborate results from other studies although it is generally assumed that sex is not a risk factor for infection with Blastocystis ([@B18]).

We sought to elucidate the distribution of *Blastocystis* subtypes in humans in southwest of Iran. ST1, ST2 and ST3 were identified, confirming the trend observed in other studies carried out in countries outside Europe. Hence, no cases of other subtypes were found. ST4 is common in humans in Europe, but appears to be rare in countries outside Europe ([@B19]). In this study, ST3 was the most prevalent (58.34%), as the pre-dominant subtype in most parts of the world such as Japan, Pakistan, Bangladesh, Germany, Singapore, Greece, Turkey, Makkah, Thailand and Iran ([@B2], [@B5], [@B7]-[@B9], [@B10], [@B11], [@B17], [@B19]-[@B24]). It is believed that ST3 is the main human subtype and has no relation to geographic area ([@B25]-[@B27]). Moosavi and colleagues (2012) also identified ST1, ST2, and ST3 in humans; however, these authors also found a few cases of ST7 ([@B5]), which has been found sporadically in humans in other studies ([@B4], [@B26], [@B27]). ST5 is the subtype seen in cattle and pigs ([@B28]), and human infection with this subtype has been rarely reported ([@B25], [@B28]). Since *Blastocystis* is a zoonotic parasite, the impact of geographical terms on infection should be considered.

There has been debate on the pathogenicity of *Blastocystis*. A few studies found that expatriates with traveler's diarrhea had a high prevalence of *Blastocystis*, whereas some studies found that 25%--75% of those with *Blastocystis* have a history of recent foreign travel ([@B29]-[@B32]). Some studies suggest an association between the parasite and symptoms ([@B32]-[@B34]), while others do not ([@B35], [@B36]).

*Blastocystis* can be isolated from individuals with gastrointestinal and extra-intestinal symptoms (e.g. diarrhea, nausea, abdominal pain, bloating, vomiting or anorexia) and asymptomatic individuals with an almost equal prevalence ([@B32]). In some studies, higher prevalence can be found in asymptomatic compared to symptomatic individuals. Many researchers classify *Blastocystis* as a commensal or opportunistic pathogen ([@B37]). In this study, we compared clinical signs and infection with *Blastocystis*. A significant correlation was found between Blastocystis infection with diarrhea and stomach pain. However, no significant correlation was observed between different subtype and clinical signs. Scanlan suggested that studies about the clinical relevance of different *Blastocystis* subtypes, their virulence, and the zoonotic potential within and between humans and animals can fill the gaps of incomplete knowledge about the pathogenicity of Blastocystis ([@B38]).

Clinical symptoms are diverse, ranging from acute diarrhea to mild chronic abdominal pain. Although the parasite is noninvasive, it might complicate the pathogenicity of other invasive pathogens. The diversity in pathogenesis between variant parasite subtypes is suspected to be responsible for diverse clinical symptoms and presentations of Blastocystis infections ([@B39]).

The results of the present study implicated that more than one third of referred individuals (40.29%) were infected with one or more intestinal parasites. Our findings showed that protozoa infections (39.80%) were remarkably more common compared to helminthes infections (0.49%) and except *Blastocystis*, *Endolimax* *nana*, *Entamoeba* *coli* and *Giardia* *lamblia* were the most frequently detected protozoan parasites.

One of the limitations of our study was that PCR was not performed on DNAs extracted from negative samples by the two screening methods, both of which have reduced sensitivity compared with PCR ([@B37], [@B40]). To this end, it should be emphasized that the numbers of positive samples identified in the current study should by no means be interpreted as prevalence figures. We acknowledge the limitations related to methods used for *Blastocystis* screening (microscopy and culture), one of which is related to the possibility that for instance avian *Blastocystis* sp isolates may not establish in cultures kept at 37^o^C.
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